EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown

Joanna E Parkes iD, Caecilie M M Benckendorff, Anna L Malinowska, Jacob Roberts, Harley L Huynh, Sritama Bose iD, Loïc M Cochard, Aisling Ní Cheallaigh, Sarah L Lovelock iD, Peter L Oliver iD, Gavin J Miller iD

ChemBioChem · 2026

DOI: 10.1002/cbic.70533 ↗

At a glance

Journal article in ChemBioChem, 2026. Written by Joanna E Parkes and 10 co-authors. Institution: MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK. Major MEDLINE topics: PTEN Phosphohydrolase, Oligonucleotides, Antisense, Thiouridine. 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, UK Medical Research Council.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Gapmer antisense oligonucleotides (ASOs) represent a clinically validated therapeutic platform, with a 2′‐ O ‐methoxyethyl modification commonplace within the flanking regions. An alternative sugar modification, incorporation of 4′‐thioribose, has demonstrated enhanced nuclease resistance in siRNAs and aptamers, but incorporation of this motif into gapmer architectures remains underexplored. Herein, we report the synthesis of a 4′‐thiouridine phosphoramidite building block and its incorporation into gapmer ASOs targeting PTEN . Evaluation of sequences containing 4′‐thiouridine in the flanking regions (compared with 2′‐ O ‐methoxyethyl) and varying phosphorothioate linkage composition demonstrates that the modified gapmers maintain equivalent knockdown efficacy under transfection and gymnotic delivery. These findings indicate 4′‐thioribose as an alternative sugar modification for wider exploration within gapmer ASOs.

Subjects

MeSH terms (MEDLINE)

PTEN PhosphohydrolaseOligonucleotides, AntisenseThiouridineHumansGene Knockdown TechniquesOrganophosphorus Compounds

Author keywords

PTENaptamergene knockdownnucleaseoligonucleotidephosphoramiditesmall interfering RNA

Substances

PTEN PhosphohydrolaseOligonucleotides, AntisensePTEN protein, humanThiouridineOrganophosphorus Compoundsphosphoramidite

Authors and institutions

  • MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK.
  • Manchester Institute of Biotechnology & Department of Chemistry, University of Manchester, Manchester, UK.

ORCID profiles: Joanna E Parkes, Sritama Bose, Sarah L Lovelock, Peter L Oliver, Gavin J Miller

Funding

  • Medical Research Council
  • UK Medical Research Council

Cite

APA

Parkes, J. E., Benckendorff, C. M. M., Malinowska, A. L., Roberts, J., Huynh, H. L., Bose, S., Cochard, L. M., Cheallaigh, A. N., Lovelock, S. L., Oliver, P. L., & Miller, G. J. (2026). A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. https://doi.org/10.1002/cbic.70533

Vancouver

Parkes JE, Benckendorff CMM, Malinowska AL, Roberts J, Huynh HL, Bose S, et al. A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. 2026. doi:10.1002/cbic.70533

BibTeX
@article{Parkes2026,
  author = {Parkes, Joanna E and Benckendorff, Caecilie M M and Malinowska, Anna L and Roberts, Jacob and Huynh, Harley L and Bose, Sritama and Cochard, Loïc M and Cheallaigh, Aisling Ní and Lovelock, Sarah L and Oliver, Peter L and Miller, Gavin J},
  title = {A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown},
  journal = {ChemBioChem},
  year = {2026},
  doi = {10.1002/cbic.70533}
}
Start for free →